Login    Join free Add to favorites    中文
Home >Products> Reagents >Other Reagents> Approved Drug Library
Approved Drug Library
Approved Drug Library
Origin of place China
Model
Supplier Wuhan Ecalbio Co., Ltd
Price
Hits 653
Updated 9/11/2025
  • Product Detail
  • Company Profile

Description
ECALBIO Approved Drug Library includes 2,818 FDA, EMA, and NMPA-approved drug compounds, ideal for initial screening in drug discovery. Compounds are provided in DMSO and stored in 96-well V-bottom plates, each plate sealed with aluminum foil and labeled with a barcode for easy identification.
 
These compounds have passed extensive preclinical and clinical studies, with verified biological activity and safety, suitable for high-throughput screening (HTS) and high-content screening (HCS), especially large-scale screenings with fewer repetitions.

Traditional new drug development involves multiple steps such as target validation, compound screening, candidate compound selection, preclinical studies, and clinical trials, which is time-consuming and costly [1].
 
In recent years, drug repurposing has gained attention as a cost-effective approach, utilizing compounds with known safety profiles, bioactivity, and pharmacokinetics to speed up the development process and minimize failure risks [2].
 
This library enables rapid drug repurposing by identifying new targets and reduces costs and timelines for drug development.
The chemical information in this library is comprehensive, including the compound’s English name, CAS number, molecular weight, target pathways, structure, IC50 values, and activity descriptions.
 
The compounds in the library cover a wide range of research areas, including oncology, cardiovascular drugs, anti-inflammatory agents, immunology, neurology, respiratory drugs, dermatology, endocrinology, and more.
The compounds also target a variety of signaling pathways including Anti-infection, Apoptosis, Autophagy, DNA Damage/Repair, GPCR, NF-κB, PI3K/Akt/mTOR, JAK/STAT, Tyrosine Kinase, TGF-β/Smad, MAPK/ERK, Metabolism, Neuroscience, Stem Cells, Immunology/Inflammation, Microbiology/Virology, and Membrane Transporters/Ion Channels.
 
Quality assurance: The compounds feature diverse structures, significant pharmacological activity, and are cell-permeable. Additionally, all compounds have been tested by NMR and HPLC/LCMS to ensure their structural integrity and high purity.
 
User-friendly: The 2818 drugs are stored in 96-well V-bottom plates, compatible with both automated instruments and manual drug dispensing using a pipette or for individual validation. The V-bottom design minimizes the dead volume for efficient compound use. The first and twelfth columns of each plate are left empty for controls to reduce edge effects.
This library is particularly suited for large-scale screening. All compounds are provided at 10 mM in 10μl volumes, sufficient for 50 screenings in 96-well plates or 200 screenings in 384-well plates.
 
Specifications
36psc  96plates
 
Storage and Expiry Date
Store at -20℃, stable for at least one year; or store at -80℃, stable for at least two years.

 



ECALBIO CO.,LTD    
Email: info@ecalbio.com     
Tel: 86-27-87745856    
Add : HZAU, Luoshi Road, Wuhan City 430000, China.
bio-equip.cn
Request Infomation

* Name:
Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request infomation:
yes no
Request Quotation:
yes no
* Message:
Validated Code:
refresh
I agree to share my inquiry to the other matching suppliers.



Recently viewed products
Copyright(C) 2006-2025 Bio-Equip    E-mail:web@bio-equip.cn   沪ICP备06040519号